Tate & Lyle PLC
Disposal of International Sugar Trading
Tate & Lyle PLC ('Tate & Lyle') announces the sale of its international sugar
trading operations to Bunge Limited ('Bunge') for an undisclosed amount.
The disposal, which is conditional on anti-trust approval in a small number of
countries, represents another step in delivering on Tate & Lyle's strategy of
reducing its exposure to volatile commodity markets.
As a first stage, the operations and the employees of the international sugar
trading business will transfer to Bunge. The working capital in the business
will remain with, and be collected and paid by, Tate & Lyle through to 31 March
2009 at which point it will be assumed by Bunge upon final completion of the
transaction.
The disposal will allow Tate & Lyle Sugars to concentrate on its core sugar
refining operations. In conjunction with the sale, the raw cane sugar sourcing
team in the Group's EU sugar refining operations is being strengthened to ensure
it has the appropriate resources going forward to support and develop its key
supplier relationships.
Iain Ferguson, Chief Executive of Tate & Lyle said:
'Our international sugar trading operation is a good business. However, the
recent sale of our sugar businesses in the Americas and the restrictions on
exports from our EU cane sugar refineries, which were implemented as part of the
EU Sugar Regime reforms, have reduced the value of international sugar trading
to Tate & Lyle. I would like to take this opportunity to thank our employees in
this business for their commitment and hard work over the years and wish them
every future success within the Bunge organization.'
The gross assets attributable to the business being sold had a value of £288
million at 31 March 2008; net operating assets had a value of £106 million at 31
March 2008 and related primarily to working capital. A small number of minority
interests related to the sugar trading business are not included in the sale and
will be addressed separately over the coming months in accordance with the
related shareholders' agreements. The sale of the international sugar trading
business and the anticipated disposal of the minority interests are together
unlikely to generate a material profit or loss on disposal; the sale of some of
the minority interests may occur in the 2010 financial year.
For more information contact Tate & Lyle PLC:
Tim Lodge, Director of Investor Relations
Tel: 020 7626 6525 or Mobile: 07798 837317
Rowan Adams, Director of Corporate Communications (Media)
Tel: 020 7626 6525 or Mobile 07713 067 542
Notes to Editors
1. Tate & Lyle's international sugar trading business made an operating profit
of £2 million in the two months to 31 May 2008, an operating loss of £9 million
in the year ended 31 March 2008, and an operating profit of £22 million in the
year ended 31 March 2007.
2. The results of this business will be reclassified as discontinued operations.
A restatement of Tate & Lyle's accounts for the six months ended 31 September
2007 and for the year ended 31 March 2008 will be published on the Company's
website www.tateandlyle.com.
3. The sale excludes Tate & Lyle's shareholding in its subsidiary in Israel,
Tate & Lyle Gadot Manufacturing, and the minority interests in sugar facilities
in Saudi Arabia, Egypt and Thailand.
4. Tate & Lyle's Annual General Meeting will be held on 23 July 2008 on which
day we will also publish our Interim Management Statement for the three months
ended 30 June 2008.
About Tate & Lyle
Tate & Lyle is a world-leading renewable food and industrial ingredients
company, serving a global market from over 50 production facilities throughout
the Americas, Europe and South East Asia. Our efficient, large-scale
manufacturing plants turn agricultural products, corn and cane sugar, into
valuable ingredients for our customers. These ingredients add taste, texture,
nutrition and increased functionality to products that millions of people around
the world use or consume every day.
Tate & Lyle's range of leading branded food ingredients includes SPLENDA(R)
Sucralose, PROMITOR(TM) Dietary Fiber, STA-LITE(R) Polydextrose, Tate & Lyle
Fairtrade Sugar and Lyle's Golden Syrup. Tate & Lyle also produces branded
industrial ingredients including Bio-PDO(TM), Ethylex(R) and STA-Lock(R) paper
starches; and staple ingredients such as high fructose corn syrup, sugar,
ethanol, citric acid and basic starches. In addition to providing a wide range
of ingredients our expert sales and product applications teams support customers
by providing technical advice and proprietary consumer insight studies.
Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L.
American Depositary Receipts trade under TATYY. In the year to 31 March 2008,
Tate & Lyle employed 6,488 people in its subsidiaries and joint ventures, and
sales totalled £3.4 billion. http://www.tateandlyle.com. SPLENDA(R) is a
trademark of McNeil Nutritionals, LLC
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.